Henry Schein Inc (NAS:HSIC)
$ 68 -1.43 (-2.06%) Market Cap: 8.48 Bil Enterprise Value: 11.34 Bil PE Ratio: 27.87 PB Ratio: 2.43 GF Score: 83/100

Henry Schein Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 12:30PM GMT
Release Date Price: $73.88 (+0.12%)
Michael Roman Minchak
JPMorgan Chase & Co, Research Division - Analyst

Good morning, and thank you all for joining us today as we kick off day 3 of the JPMorgan Healthcare Conference. My name is Michael Minchak, and I'm a member of the Healthcare Services Equity Research team here at JPMorgan.

With us for this next session is the management team from Henry Schein. The company is one of the leading providers of products and services to office-based practitioners in the dental and medical markets on a global basis. So it's my pleasure to introduce CEO, Stanley Bergman; and CFO, Steve Paladino. Thank you both for joining us today.

We're going to be doing a fireside chat format today. But before we do that, I'm going to hand it over to Steve, who's going to give us the forward-looking statement, and then Stan will make some introductory comments, and then we'll get into Q&A. (Operator Instructions)

So with that, I will turn it over to Steve.

Steven Paladino
Henry Schein, Inc. - Executive VP, CFO & Executive Director

Okay.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot